UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Invesco China Technology ETF
CQQQ
$3.3B
| $1.1M | ﹤0.01% |
32,842
-15,197
| -32% | -$520K |
|
4327
Healthcare Services Group
HCSG
$1.5B
| $1.1M | ﹤0.01% |
104,081
-8,890
| -8% | -$98.6K |
|
4328
CALL
Shift4
FOUR
$3.41B
| $1.1M | ﹤0.01% |
+15,000
| New | +$994K |
|
|
MMT
4329
Aberdeen Multi-Market Income Fund
MMT
$243M
| $1.1M | ﹤0.01% |
234,098
-87,792
| -27% | -$404K |
|
4330
iShares MSCI Agriculture Producers ETF
VEGI
$147M
| $1.09M | ﹤0.01% |
30,553
-9,010
| -23% | -$334K |
|
|
OLP
4331
One Liberty Properties
OLP
$512M
| $1.09M | ﹤0.01% |
46,523
-12,097
| -21% | -$280K |
|
|
MUE
4332
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
| $1.09M | ﹤0.01% |
106,930
-37,333
| -26% | -$371K |
|
4333
Edgewise Therapeutics
EWTX
$4.84B
| $1.09M | ﹤0.01% |
60,510
-13,608
| -18% | -$237K |
|
4334
abrdn Physical Palladium Shares ETF
PALL
$683M
| $1.09M | ﹤0.01% |
61,135
+19,520
| +47% | +$350K |
|
|
EFR
4335
Eaton Vance Senior Floating-Rate Fund
EFR
$319M
| $1.09M | ﹤0.01% |
83,274
+21
| +0% | +$275 |
|
4336
Talos Energy
TALO
$2.6B
| $1.09M | ﹤0.01% |
89,439
-78,798
| -47% | -$983K |
|
|
BCV
4337
Bancroft Fund
BCV
$140M
| $1.09M | ﹤0.01% |
69,289
-9,157
| -12% | -$141K |
|
|
BZUN
4338
Baozun
BZUN
$170M
| $1.09M | ﹤0.01% |
463,811
+455,457
| +5,452% | +$1.18M |
|
4339
PIMCO Corporate & Income Opportunity Fund
PTY
$2.52B
| $1.08M | ﹤0.01% |
75,786
-856
| -1% | -$12.2K |
|
4340
Travere Therapeutics
TVTX
$5.74B
| $1.08M | ﹤0.01% |
131,506
-241,105
| -65% | -$1.62M |
|
|
VZIO
4341
CALL
DELISTED
VIZIO Holding Corp.
VZIO
| $1.08M | ﹤0.01% |
100,000
+60,300
| +152% | +$645K |
|
|
NARI
4342
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.08M | ﹤0.01% |
22,425
-13,499
| -38% | -$598K |
|
4343
PUT
Core Scientific
CORZ
$6.25B
| $1.08M | ﹤0.01% |
+116,000
| New | +$593K |
|
|
TYG
4344
Tortoise Energy Infrastructure Corp
TYG
$1.08B
| $1.08M | ﹤0.01% |
30,931
+696
| +2% | +$22.6K |
|
4345
First Advantage
FA
$4.05B
| $1.08M | ﹤0.01% |
67,006
-94,737
| -59% | -$1.53M |
|
4346
CALL
eBay
EBAY
$47.9B
| $1.07M | ﹤0.01% |
20,000
| – | – |
|
4347
ManpowerGroup
MAN
$2.63B
| $1.07M | ﹤0.01% |
15,365
-46,060
| -75% | -$3.41M |
|
4348
iShares MSCI Japan Small-Cap ETF
SCJ
$260M
| $1.07M | ﹤0.01% |
15,103
-11,697
| -44% | -$847K |
|
4349
MaxLinear
MXL
$6.21B
| $1.07M | ﹤0.01% |
53,214
-10,865
| -17% | -$214K |
|
4350
ACI Worldwide
ACIW
$5.34B
| $1.07M | ﹤0.01% |
27,066
-58,029
| -68% | -$2.02M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.